Catadegbrutinib, CAS [[2736508-60-2]]

Produktübersicht

• Artikelname: Catadegbrutinib, CAS [[2736508-60-2]]
• Artikelnummer: MCE-HY-160141
• Hersteller Artikelnummer: HY-160141
• Alternativnummer: MCE-HY-160141-10MG,MCE-HY-160141-50MG,MCE-HY-160141-5MG,MCE-HY-160141-1MG,MCE-HY-160141-25MG,MCE-HY-160141-10MMX1ML,MCE-HY-160141-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BGB-16673, BTK-IN-29

Produktbeschreibung

BGB-16673 (BGB-16673, BTK-IN-29) is an orally active, selectively chimeric degradation activator compound (CDAC), targeting BTK (IC50=0.69 nM). BGB-16673 ligates BTK to E3 ubiquitin ligase, causing BTK to undergo polyubiquitination, which is then recognized and degraded by the proteasome, thereby exerting efficient BTK degradation activity. BGB-16673 can be used in the research of B-cell malignancies such as chronic lymphocytic leukemia, small lymphocytic lymphoma, and mantle cell lymphoma[1][2][3].

Produkteigenschaften

• Molekulargewicht: 851.01
• Reinheit: 97.79
• CAS Nummer: [2736508-60-2]
• Formel: C47H54N12O4
• Target-Kategorie: Btk,PROTACs

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound